Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma

Clinical trial NCT00829179 · COMPLETED

Trial details

NCT number: NCT00829179
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Asthma

Start date: 2002-10-01
Primary completion: 2004-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.